These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 29306435)
1. Fluorescence-Quenched Substrates for Quantitative Live Cell Imaging of Glucocerebrosidase Activity. Ashmus RA; Shen DL; Vocadlo DJ Methods Enzymol; 2018; 598():199-215. PubMed ID: 29306435 [TBL] [Abstract][Full Text] [Related]
2. Fluorescence-quenched substrates for live cell imaging of human glucocerebrosidase activity. Yadav AK; Shen DL; Shan X; He X; Kermode AR; Vocadlo DJ J Am Chem Soc; 2015 Jan; 137(3):1181-9. PubMed ID: 25562638 [TBL] [Abstract][Full Text] [Related]
3. Measurement of GCase Activity in Cultured Cells. Shojima Y; Ogata J; Tsunemi T; Imai Y; Hattori N Methods Mol Biol; 2021; 2322():47-52. PubMed ID: 34043191 [TBL] [Abstract][Full Text] [Related]
4. Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells. Naito Y; Sakamoto S; Kojima T; Homma M; Tanaka M; Matsui H SLAS Discov; 2023 Oct; 28(7):344-349. PubMed ID: 37369311 [TBL] [Abstract][Full Text] [Related]
5. A Fixable Fluorescence-Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells. Zhu S; Deen MC; Zhu Y; Gilormini PA; Chen X; Davis OB; Chin MY; Henry AG; Vocadlo DJ Angew Chem Int Ed Engl; 2023 Oct; 62(40):e202309306. PubMed ID: 37582679 [TBL] [Abstract][Full Text] [Related]
6. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease. Wong YC; Krainc D Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775 [TBL] [Abstract][Full Text] [Related]
7. Activation and Purification of ß-Glucocerebrosidase by Exploiting its Transporter LIMP-2 - Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease. Dobert JP; Bub S; Mächtel R; Januliene D; Steger L; Regensburger M; Wilfling S; Chen JX; Dejung M; Plötz S; Hehr U; Moeller A; Arnold P; Zunke F Adv Sci (Weinh); 2024 Jul; 11(25):e2401641. PubMed ID: 38666485 [TBL] [Abstract][Full Text] [Related]
8. Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells. Ambrosi G; Ghezzi C; Zangaglia R; Levandis G; Pacchetti C; Blandini F Neurobiol Dis; 2015 Oct; 82():235-242. PubMed ID: 26094596 [TBL] [Abstract][Full Text] [Related]
9. Activity-Based Probes for Glycosidases: Profiling and Other Applications. Kuo CL; van Meel E; Kytidou K; Kallemeijn WW; Witte M; Overkleeft HS; Artola ME; Aerts JM Methods Enzymol; 2018; 598():217-235. PubMed ID: 29306436 [TBL] [Abstract][Full Text] [Related]
10. A versatile fluorescence-quenched substrate for quantitative measurement of glucocerebrosidase activity within live cells. Deen MC; Zhu Y; Gros C; Na N; Gilormini PA; Shen DL; Bhosale S; Anastasi N; Wang R; Shan X; Harde E; Jagasia R; Lynn FC; Vocadlo DJ Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2200553119. PubMed ID: 35858317 [TBL] [Abstract][Full Text] [Related]
11. Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation. Bae EJ; Yang NY; Lee C; Lee HJ; Kim S; Sardi SP; Lee SJ Exp Mol Med; 2015 Mar; 47(3):e153. PubMed ID: 25813221 [TBL] [Abstract][Full Text] [Related]
12. The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson's therapeutics. Rubilar JC; Outeiro TF; Klein AD Brain; 2024 Aug; 147(8):2610-2620. PubMed ID: 38437875 [TBL] [Abstract][Full Text] [Related]
13. Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates. Deen MC; Proceviat C; Shan X; Wu L; Shen DL; Davies GJ; Vocadlo DJ ACS Chem Biol; 2020 Apr; 15(4):824-829. PubMed ID: 32109051 [TBL] [Abstract][Full Text] [Related]
14. Axonal Transport of Lysosomes Is Unaffected in Glucocerebrosidase-Inhibited iPSC-Derived Forebrain Neurons. Keefe AJ; Gabrych DR; Zhu Y; Vocadlo DJ; Silverman MA eNeuro; 2023 Oct; 10(10):. PubMed ID: 37816595 [TBL] [Abstract][Full Text] [Related]
17. Glucocerebrosidase, a new player changing the old rules in Lewy body diseases. Yang NY; Lee YN; Lee HJ; Kim YS; Lee SJ Biol Chem; 2013 Jul; 394(7):807-18. PubMed ID: 23435096 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease. Stojkovska I; Krainc D; Mazzulli JR Cell Tissue Res; 2018 Jul; 373(1):51-60. PubMed ID: 29064079 [TBL] [Abstract][Full Text] [Related]
19. Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1. Akiyama H; Kobayashi S; Hirabayashi Y; Murakami-Murofushi K Biochem Biophys Res Commun; 2013 Nov; 441(4):838-43. PubMed ID: 24211208 [TBL] [Abstract][Full Text] [Related]
20. A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide. Motabar O; Goldin E; Leister W; Liu K; Southall N; Huang W; Marugan JJ; Sidransky E; Zheng W Anal Bioanal Chem; 2012 Jan; 402(2):731-9. PubMed ID: 22033823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]